News und Analysen
AMD's Data Center Business Doubled to $6.7 Billion. The Stock Fell 9% Because of What That Growth Costs.
Shares of Advanced Micro Devices (NASDAQ: AMD) fell about 9% in Tuesday's after-hours session after the chipmaker reported its second-quarter results. That was just hours after the stock closed the
Santen Joins Inaugural Global Summit for Eye Health as High-Impact Partner
EQS-News: Formycon invites to conference call on 2026 half-year results and announces participation in international investor conferences
Why Vertex Pharmaceuticals Stock Ticked Higher on Tuesday
A banner Tuesday for U.S. stocks was also a prosperous one for Vertex Pharmaceuticals' (NASDAQ: VRTX) shares. The company reported encouraging, if not spectacular, quarterly results, and investors
EQS-News: #FutureFresenius: Excellent Q2 performance demonstrates structural step-up – Guidance raised
EQS-Adhoc: Fresenius SE & Co. KGaA: Fresenius raises its earnings guidance for fiscal year 2026 due to strong operational business performance
Advanced Micro Devices vs. Intel: Which Technology Stock Is a Better Buy in 2026?
The semiconductor landscape is shifting rapidly as artificial intelligence demands redefine hardware requirements for global enterprises. Choosing between Advanced Micro Devices Inc (NASDAQ:AMD) and
Prediction: These 2 Stocks Will Keep Winning No Matter What the Market Does
Even with recent geopolitical tensions and macroeconomic challenges, broader equities have performed fairly well this year. But how long will that last? Perhaps these headwinds will, eventually
Stanley Druckenmiller Put 18% of His $3.4 Billion Portfolio in This One Stock. Is Natera a Buy?
It can pay to track what the big investors on Wall Street are trading in quarterly 13-F filings. This quarter, legendary hedge fund manager Stanley Druckenmiller added to his largest stock position
3 of the Best Dividend Stocks to Buy in August 2026
Dividend stocks can be highly valuable investments to hold for the long term. In addition to dividend income, they have the potential to generate slow but modest gains over time. The problem these
IonQ vs. Advanced Micro Devices: Comparing Revenue Trends Between a Quantum Computing Innovator and an Artificial Intelligence Giant
IonQ (NYSE:IONQ) primarily generates revenue by developing general-purpose quantum computing systems and providing access through various cloud services.
The company finalized its acquisition of
Nvidia vs. Advanced Micro Devices: Evaluating Revenue Growth Trajectories for These Artificial Intelligence Giants
Nvidia (NASDAQ:NVDA) primarily generates its revenue by designing and supplying advanced graphics, compute, and networking solutions used heavily across gaming and high-performance computing
Stanley Druckenmiller Holds Taiwan Semiconductor After Its Q2 Beat, Betting Chip Demand From Nvidia and AMD Keeps Growing
Legendary investor Stanley Druckenmiller sold 47,805 shares of Taiwan Semiconductor Manufacturing (NYSE: TSM) in the first quarter of 2026. After the sale, the stake was still worth $167 million at
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Why Supernus Pharmaceuticals Stock Topped the Market Today
Supernus Pharmaceuticals (NASDAQ: SUPN) began the stock trading week on a high note, announcing a major merger alongside its latest quarterly earnings release.
Investors ultimately decided to be
Pfizer's Stock Has Been a Dud Over the Past 5 Years, but Is It Still Worth Buying for Its 6.9% Yield?
Stocks that don't generate strong returns can still make good dividend investments. As long as their payouts are sustainable and the businesses are in solid shape, they can be appealing options for
EQS-Adhoc: Fresenius Medical Care AG : Fresenius Medical Care reports operating income excluding special items to be above market expectations in Q2 2026 and confirms its outlook for the financial year 2026
Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Billionaire Stanley Druckenmiller Bought This Biotech Stock That Has Surged 400%. Is It Still a Buy?
Stanley Druckenmiller isn't afraid to take risks. His boldness has paid off through the years. Druckenmiller's net worth stands at $7.8 billion. His Duquesne Family Office has roughly $3 billion in
AMD Reports Tuesday. One Number Decides Whether 54 Times Forward Earnings Was Ever Defensible.
Advanced Micro Devices (NASDAQ: AMD) reports its second-quarter results on Tuesday, Aug. 4, after the market closes, with an earnings call to follow at 5 p.m. ET. The chipmaker confirmed the date in
AEVIS VICTORIA SA (AEVS.SW) – MRH Switzerland AG continues to grow and outperforms the Swiss hotel market in the first half of 2026
Jeff Bezos Backed a $2.6 Billion AI Startup That's Partnering With Nvidia and Meta on New Chip Materials
For years, the technology industry's been working to extract enough performance from silicon to make modern-day artificial intelligence (AI) possible. Now that it's done so, it's using that very
An IQVIA Insider Sold Just Before the Stock Slipped. Here's What Long-Term Investors Should Know
Keriann Cherofsky, an executive at IQVIA Holdings Inc. (NYSE:IQV), sold 558 shares on July 29, 2026, for a total value of about $136,827, according to an SEC Form 4 filing.
IQVIA Holdings Inc. is a
Why Billionaire Stanley Druckenmiller and Wall Street Analysts Love This Biotech Stock
Shares of biotechnology company Revolution Medicines (NASDAQ: RVMD) have surged more than 134% so far this year. Billionaire investor Stanley Druckenmiller's Duquesne Family Office drew attention to
An IQVIA Insider Just Sold Over $1 Million in Stock. Here's What Long-Term Investors Should Know
Eric Sherbet, an executive at IQVIA Holdings Inc. (NYSE:IQV), sold 5,000 shares of common stock on July 29, 2026, according to a recent SEC Form 4 filing.
Transaction value based on SEC Form 4